Skip to content

Led treatment for burn healing

Low intensity led therapy (658nm) for burn healing: a non-randomized, double-blind and controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3mbdx6
Enrollment
Unknown
Registered
2017-04-10
Start date
2016-12-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Second degree burn

Interventions

The 20 participants will be randomly allocated into two groups of the same size. The experimental group, with 10 participants, will be submitted to irradiation with light emitting diode, 658nm wavelen
Device
E02.774
E02.594.540

Sponsors

Universidade Estadual do Piauí
Lead Sponsor
Centro Universitário Uninovafapi
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: They nedd to have a seconddegree burn in the region of the arm, forearm, thorax or lower limbs; age between 18 and 60 years;to be in the hospital for second degree burn treatment in the Burn Therapy Unit; to be hemodynamically stable according to blood pressure, diuresis, heart rate and respiratory rate, axillary temperature and transcutaneous oxygen saturation.

Exclusion criteria

Exclusion criteria: Patient with blood dyscrasia with predisposition to hemorrhage; presence of gangrene, renal failure, pregnancy or photosensitivity; bacterial infection at the burn site; patient with hypotension, tachycardia, tachypnea, oliguria or cyanosis; patients with comorbidities that may interfere with the healing process, such as: diabetes mellitus, malnutrition, obesity and smoking; patients who use illicit drugs or medications that interfere with the healing process of wounds, such as: chemotherapy and antibiotics.

Design outcomes

Primary

MeasureTime frame
Acceleration of healing. Evaluated by clinical visual inspection and recorded by photograph. Aspects to be considered: wound area, amount of exudate and appearance of the wound. ;Morphometric evaluation of the wound area by the healing index. Refers to the calculation of the area of the wound before and after the intervention, presented in percentage of healing.

Secondary

MeasureTime frame
Biopsy before and after intervention. Histomorphometric evaluation with inflammatory cell counts, fibroblast counts and collagen proliferation area using histological sections stained with hematoxylin and eosin, Masson trichrome and picro syrius red.;Analysis of the qualitative composition of the tissue by FT Raman spectroscopy. It is expected that there will be an increase in the spectroscopic peaks relative to the amino acids, which is directly related to the protein components. Increased local protein may indicate increased collagen in the healing process.

Countries

Brazil

Contacts

Public ContactDenyberg;Rauirys Santiago;Oliveira

Centro Universitário Uninovafapi;Centro Universitário Uninovafapi

dosantiago@uninovafapi.edu.br;raoliveira@uninovafapi.edu.br+55(86)21060700;+55(86)21060700

Outcome results

None listed

Source: REBEC (via WHO ICTRP)